VPS4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.632000E-01
Normal-vs-Stage2
4.159600E-01
Normal-vs-Stage3
9.103800E-02
Normal-vs-Stage4
8.569400E-01
Stage1-vs-Stage2
9.315000E-01
Stage1-vs-Stage3
2.175400E-01
Stage1-vs-Stage4
5.060600E-01
Stage2-vs-Stage3
1.188610E-01
Stage2-vs-Stage4
5.371800E-01
Stage3-vs-Stage4
2.169600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.862400E-01
Normal-vs-AfricanAmerican
9.763400E-01
Normal-vs-Asian
1.190760E-01
Caucasian-vs-AfricanAmerican
2.519400E-01
Caucasian-vs-Asian
1.104420E-01
AfricanAmerican-vs-Asian
7.826500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.378000E-01
Normal-vs-Female
5.362400E-01
Male-vs-Female
3.370400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.024200E-01
Normal-vs-Age(41-60Yrs)
8.440800E-01
Normal-vs-Age(61-80Yrs)
2.584200E-01
Normal-vs-Age(81-100Yrs)
3.694200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.356800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.630000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.946200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.357200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.469800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.834950E-01
Normal-vs-Daily Drinker
1.316580E-01
Normal-vs-Weekly Drinker
2.669000E-01
Normal-vs-Occasional Drinker
8.769800E-01
Normal-vs-Social Drinker
5.419600E-01
Non Drinker-vs-Daily Drinker
4.503800E-01
Non Drinker-vs-Weekly Drinker
6.229800E-01
Non Drinker-vs-Occasional Drinker
7.255000E-03
Non Drinker-vs-Social Drinker
3.454800E-01
Daily Drinker-vs-Weekly Drinker
9.276200E-01
Daily Drinker-vs-Occasional Drinker
3.803000E-03
Daily Drinker-vs-Social Drinker
1.642620E-01
Weekly Drinker-vs-Occasional Drinker
2.614300E-02
Weekly Drinker-vs-Social Drinker
3.100600E-01
Occasional Drinker-vs-Social Drinker
1.817420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.232100E-02
Normal-vs-Grade 2
1.876190E-02
Normal-vs-Grade 3
1.167650E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.142400E-01
Grade 1-vs-Grade 3
1.113200E-01
Grade 1-vs-Grade 4
7.232100E-02
Grade 2-vs-Grade 3
4.200000E-02
Grade 2-vs-Grade 4
1.876190E-02
Grade 3-vs-Grade 4
1.167650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.307600E-01
Normal-vs-NonDiabetic
2.999000E-01
Diabetic-vs-NonDiabetic
4.725800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.185600E-02
Normal-vs-NoPancreatitis
3.293400E-01
Pancreatitis-vs-NoPancreatitis
6.811800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.764800E-01
Normal-vs-N1
4.451600E-01
N0-vs-N1
8.038200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.334200E-01
Normal-vs-TP53-NonMutant
8.208000E-01
TP53-Mutant-vs-TP53-NonMutant
4.891400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
